The ReWalk Exoskeletal Walking System for Persons With Paraplegia (VA_ReWalk)
It is well appreciated that an extreme sedentary lifestyle from paralysis, contributes to many secondary medical problems such as diabetes and insulin resistance, obesity, constipation, poor blood pressure regulation, cardiovascular disease, reduced quality of life, and more. The ReWalk-I exoskeleton walking device permits investigation of the potential benefits of frequent upright posture and walking on many of the secondary consequences of spinal cord injury. The researchers are investigating the ability of persons with paraplegia to learn to stand and walk with the ReWalk-I and the effects of being upright and walking on several of these secondary medical consequences of spinal cord injury.
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||The ReWalk Exoskeletal Walking System for Persons With Paraplegia|
- Percent change from baseline [ Time Frame: ReWalk training at 4 and 12 weeks, and 16-week follow-up ] [ Designated as safety issue: No ]
1. To determine efficacy for mobility defined as the ability to perform the following with the ReWalk-I exoskeletal system, without staff assistance:
- Standing balance for 1 minutes with both crutches,
- Standing balance for 30 seconds with one crutch,
- Ten meter walk in ≤2 minutes,
- Walk ≥30 meters in 6-minutes, and
- Ascend, turn around and descend 4 stairs in 5 minutes.
- Percent change from baseline [ Time Frame: ReWalk training at 4 and 16 weeks, and 16-week follow-up ] [ Designated as safety issue: No ]Sitting and standing balance skills, bowel function, bladder function by survey, muscle spasms by survey, quality of life by survey, resting and exercise energy expenditure, body composition, and neurological tests. Additional mobility training will be observed for a timed-up-and-go (TUG) and a mild obstacle course (incline, decline, carpeting, step, simulated curb, walking in a figure 8)
|Study Start Date:||February 2011|
|Estimated Study Completion Date:||November 2015|
|Estimated Primary Completion Date:||April 2015 (Final data collection date for primary outcome measure)|
Potential participants will be pre-screened with the inclusion criteria for eligibility. The informed consent process will begin for those participants who have been determined to meet the inclusion criteria. After the potential participant's signed consent has been provided, further evaluations for eligibility will be performed (e.g., there are several medical and physical exclusion criteria). Those potential participants who meet both the inclusion and exclusion criteria will be eligible to enroll into the ReWalk-I study. Baseline evaluations and personalized measurements for fitting to the ReWalk-I will be performed over one week, before the training sessions begin. The ReWalk sessions will consist of a Learning Phase (12 sessions in 4 weeks) and a Training Phase (18 sessions in 6 weeks). These times may vary by each participant's ReWalk learning curve. Training will begin with sit-to-stand, stand-to-sit, and standing balance activities. Progression to walking will occur as skills advance. Each session will be an average 50 minutes, with 3 sessions per week. The skills to be learned include 1) sit-to-stand, 2) stand-to-sit, 3) 2-arm standing balance, 4) 1-arm standing balance, 5) walking, and 6) stair climbing. The study evaluations will be repeated after the Learning Phase, after the Training Phase and 1-month post training follow-up.
|United States, New York|
|James J. Peters Veterans Affairs Medical Center; Center of Excellence for the Major Consequences of SCI.||Recruiting|
|Bronx, New York, United States, 10468|
|Contact: Pierre K Asselin, MSBioMedEng 718-584-9000 ext 3124 firstname.lastname@example.org|
|Contact: Drew Fineberg, BSBioMedEng 718-584-9000 ext 3130 email@example.com|
|Principal Investigator: Ann M Spungen, EdD|
|Principal Investigator:||Ann M Spungen, EdD||Bronx JJPVAMC CoE 7A-13|